Literature DB >> 23580188

0.9 % saline vs 6 % HES 130/0.4 for fluid resuscitation in critically ill patients.

Giulia Nenna1, Giorgio Costantino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23580188     DOI： 10.1007/s11739-013-0938-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  6 in total

1.  Statistical analysis plan for the Crystalloid Versus Hydroxyethyl Starch Trial (CHEST).

Authors:  John Myburgh; Qiang Li; Stephane Heritier; Arina Dan; Parisa Glass
Journal:  Crit Care Resusc       Date:  2012-03       Impact factor: 2.159

2.  Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.

Authors:  Anders Perner; Nicolai Haase; Anne B Guttormsen; Jyrki Tenhunen; Gudmundur Klemenzson; Anders Åneman; Kristian R Madsen; Morten H Møller; Jeanie M Elkjær; Lone M Poulsen; Asger Bendtsen; Robert Winding; Morten Steensen; Pawel Berezowicz; Peter Søe-Jensen; Morten Bestle; Kristian Strand; Jørgen Wiis; Jonathan O White; Klaus J Thornberg; Lars Quist; Jonas Nielsen; Lasse H Andersen; Lars B Holst; Katrin Thormar; Anne-Lene Kjældgaard; Maria L Fabritius; Frederik Mondrup; Frank C Pott; Thea P Møller; Per Winkel; Jørn Wetterslev
Journal:  N Engl J Med       Date:  2012-06-27       Impact factor: 91.245

3.  Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma).

Authors:  M F M James; W L Michell; I A Joubert; A J Nicol; P H Navsaria; R S Gillespie
Journal:  Br J Anaesth       Date:  2011-08-19       Impact factor: 9.166

4.  The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality.

Authors: 
Journal:  Intensive Care Med       Date:  2011-02-10       Impact factor: 17.440

5.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis.

Authors:  Frank M Brunkhorst; Christoph Engel; Frank Bloos; Andreas Meier-Hellmann; Max Ragaller; Norbert Weiler; Onnen Moerer; Matthias Gruendling; Michael Oppert; Stefan Grond; Derk Olthoff; Ulrich Jaschinski; Stefan John; Rolf Rossaint; Tobias Welte; Martin Schaefer; Peter Kern; Evelyn Kuhnt; Michael Kiehntopf; Christiane Hartog; Charles Natanson; Markus Loeffler; Konrad Reinhart
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

6.  Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study.

Authors:  Bertrand Guidet; Olivier Martinet; Thierry Boulain; Francois Philippart; Jean François Poussel; Julien Maizel; Xavier Forceville; Marc Feissel; Michel Hasselmann; Alexandra Heininger; Hugo Van Aken
Journal:  Crit Care       Date:  2012-05-24       Impact factor: 9.097
  6 in total
  1 in total

1.  Resuscitation fluid types in sepsis, surgical, and trauma patients: a systematic review and sequential network meta-analyses.

Authors:  Chien-Hua Tseng; Tzu-Tao Chen; Mei-Yi Wu; Ming-Cheng Chan; Ming-Chieh Shih; Yu-Kang Tu
Journal:  Crit Care       Date:  2020-12-14       Impact factor: 9.097
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.